HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$15.94
Day range
$15.99 - $16.93
Year range
$5.12 - $20.69
Market cap
1.51B USD
Avg Volume
697.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 33.86M | 53.37% |
Net income | -30.14M | -55.26% |
Net profit margin | — | — |
Earnings per share | -0.47 | -51.61% |
EBITDA | -33.38M | -51.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 318.39M | -9.53% |
Total assets | 340.04M | -7.37% |
Total liabilities | 21.20M | 4.02% |
Total equity | 318.83M | — |
Shares outstanding | 93.11M | — |
Price to book | 3.52 | — |
Return on assets | -25.99% | — |
Return on capital | -27.30% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -30.14M | -55.26% |
Cash from operations | -26.83M | -126.32% |
Cash from investing | 26.98M | 135.69% |
Cash from financing | 52.99M | 17,587.46% |
Net change in cash | 53.14M | 160.56% |
Free cash flow | -15.63M | -54.66% |
About
Founded
2017
Headquarters
Website
Employees
88